Building synthetic regulatory DNA.

I'm a PhD candidate in the Nadav Ahituv Lab at UCSF. Most of the genome doesn't code for protein; tucked inside that noncoding sequence is the regulatory DNA that controls when and where genes switch on, and where much disease-linked variation hides. I design and build synthetic regulatory DNA, then perturb it with CRISPR and sequence the readout, to test what that sequence actually does instead of guessing from annotation.

The Nadav Ahituv Lab at UCSF gathered behind a potluck table for their annual Labsgiving
The Ahituv Lab

The group I get to do this work with at UCSF, here at our annual Labsgiving.

Core areas

Research focus.

How regulatory sequence affects gene control and cellular readouts.

Gene regulation & noncoding DNA

Many disease-linked variants are in noncoding DNA. I study how regulatory sequence can change gene control and cell behavior.

UCSF Ahituv Lab profile

Functional-genomics assays

Annotation says a sequence might matter. I build assays that test what it actually does, rather than inferring function from the genome alone.

Ahituv Lab

CRISPR perturbation readouts

I perturb regulatory elements with CRISPR and read the result out by sequencing, to find which sequences actually drive a change.

Collaborate / contact
The pivot

For years I was sure I wasn't cut out for science.

I thought of myself as the athlete, not the student. At Northern Michigan, Robert Belton, PhD, helped me connect the way I learned on the mat to the way learning works in the classroom: repeat the work, get feedback, correct one thing, and come back with a better question.

That did not make science easy, but it gave me a way in. Functional genomics appealed to me because the work is explicit: make a controlled change, read the result, and pay attention to the details that do not fit your first explanation.

Orry Elor's hand-drawn schematic of the brainstem and dorsal-column sensory pathways
The method

Functional genomics asks what a sequence does.

Naming a sequence is not the point. The question is what it does. Build it, perturb it, measure the cell, and stay honest when the readout is not what you expected.

A longer-term curiosity

The long view: how people adapt.

I want to understand how people adapt when training and recovery are studied alongside the access that makes them possible.

It is an open question, not a clinical service or a promise on this site.

Where it led

The PSPG program at UCSF.

My senior-year class photo, the Pharmaceutical Sciences & Pharmacogenomics cohort I'm finishing the PhD with.

Orry Elor with his UCSF PSPG (Pharmaceutical Sciences and Pharmacogenomics) senior-year class on the Mission Bay steps
Publications

Peer-reviewed work.

Contributor to functional-genomics studies out of the Ahituv Lab and collaborators.

Neuron · 2023

Machine learning dissection of human accelerated regions in primate neurodevelopment.

Whalen S, Inoue F, Ryu H, … Elor O, … Ahituv N, Pollard KS. Neuron 111(6):857-873.

Read on Neuron · DOI
Cell Genomics · 2022

High-throughput characterization of the role of non-B DNA motifs on promoter function.

Georgakopoulos-Soares I, Victorino J, Parada GE, … Elor O, … Ahituv N. Cell Genomics 2(4):100111.

Read on Cell Genomics · DOI

Research or collaboration?

Working on something in functional genomics, or hiring in the space? Let's talk.

Contact me